emDOCs Videocast: EBM Update – Steroids in Severe CAP and CT in Post ROSC OHCA

Welcome to the emDOCs Videocast – please subscribe to our YouTube channel. These videos will cover post summaries, take homes on clinical condition, and EBM/guideline literature updates. Our first video provides EBM updates on steroids in severe community-acquired pneumonia and CT in post ROSC OHCA.

EBM Update: Steroids in Severe CAP and CT in Post ROSC OHCA

 

#1: Dequin PF, Meziani F, Quenot JP, et al; CRICS-TriGGERSep Network. Hydrocortisone in Severe Community-Acquired Pneumonia. N Engl J Med. 2023 May 25;388(21):1931-1941.

  • Question: In adult patients admitted to the ICU with severe CAP, does hydrocortisone compared to placebo reduce 28-day all-cause mortality?
  • Double-blind, placebo-controlled multicenter RCT
  • Included 795 patients > 18 years admitted to the ICU with severe PNA
  • Intervention: Hydrocortisone as a continuous infusion of 200 mg/day IV with a planned taper for 8 or 14 days compared to placebo
  • Primary Outcome: All-cause mortality at 28 days
    • Hydrocortisone 6.2% vs. Placebo 11.9%, NNT 18
  • Trial stopped early, potentially overinflated results
  • Author Takeaway: Among patients with severe community-acquired pneumonia being treated in the ICU, those who received hydrocortisone had a lower risk of death by day 28 than those who received placebo

 

#2: Meduri GU, Shih MC, Bridges L, et al; ESCAPe Study Group. Low-dose methylprednisolone treatment in critically ill patients with severe community-acquired pneumonia. Intensive Care Med. 2022 Aug;48(8):1009-1023. 

  • Question: In adult patients admitted to the ICU with severe CAP, does methylprednisolone compared to placebo reduce 60-day all-cause?
  • Prospective, multi center RCT.
  • Included 584 patients > 18 years admitted to ICU with severe PNA based on IDSA/ATS criteria
  • Primary Outcome: 60-day all-cause mortality
    • Hydrocortisone 16% vs. placebo 18%, adjusted OR 0.90 (95% CI 0.57-1.40)
  • Trial likely underpowered.
  • Author Takeaway: No difference in mortality at 60 days with methylprednisolone vs. placebo in severe CAP

 

#3: Wu JY, Tsai YW, Hsu WH, et al. Efficacy and safety of adjunctive corticosteroids in the treatment of severe community-acquired pneumonia: a systematic review and meta-analysis of randomized controlled trials. Crit Care. 2023 Jul 8;27(1):274.

  • Meta-analysis with 7 trials, 1689 patients.
  • NNT 16 for reduction in 30-day all-cause mortality; NNT 7 for reduction in need for mechanical ventilation. 

 

Bottom Line: 

  • Consider steroids for patients with severe CAP being admitted to ICU.
  • DRIP Score: https://www.mdcalc.com/calc/4050/drug-resistance-pneumonia-drip-score 
  • Azithromycin associated with reduced mortality in severe CAP admitted to ICU. Reyes LF, Garcia E, Ibáñez-Prada ED, et al. Impact of macrolide treatment on long-term mortality in patients admitted to the ICU due to CAP: a targeted maximum likelihood estimation and survival analysis. Crit Care. 2023 May 31;27(1):212. 

 

#4: Branch KRH, Gatewood MO, Kudenchuk PJ, et al. Diagnostic yield, safety, and outcomes of Head-to-pelvis sudden death CT imaging in post arrest care: The CT FIRST cohort study. Resuscitation. 2023 Jul;188:109785.

  • Question: In adult patients with ROSC post OHCA, does protocolized head-to-pelvis sudden death CT (SDCT) improve the diagnostic yield in comparison to standard practice?
  • Prospective observational pre/post cohort study including  patients successfully resuscitated from OHCA without a clear diagnosis who were stable for CT
  • Excluded < 18 years, DNR, obvious cause of arrest, severe renal dysfunction, known cardiomyopathy or obstructive CAD
  • Control (Pre): Standard approach for diagnosis post-arrest but eligible for SDCT
  • Intervention (Post): SDCT with three scans – noncontrast head, ECG-gated thoracic CTA, abd/pelvis venous phase within 6 hours
  • Primary outcome: Diagnostic yield of SDCT compared to standard practice to identify cause of arrest
  • Secondary outcome: Time to diagnosis, % correct diagnosis, diagnosis of time critical dgx, delayed dgx, AKI
  • Results
    • Standard care enrolled 143 of 273; SDCT enrolled 104 of 307
      Included 584 patients > 18 years admitted to ICU with severe PNA based on IDSA/ATS criteria
    • Primary Outcome: Diagnosis of cause of OHCA in 92% of SDCT vs. 75% in standard care
    • Secondary Outcomes: No difference in mortality, AKI, identified time critical diagnosis; SDCT – reduced time to diagnosis and delay in diagnosis of time critical conditions
  • Author Takeaway: “SDCT scanning early after OHCA resuscitation safely improved the efficiency and diagnostic yield for causes of arrest compared to the standard of care alone.”
  • Considerations: Observational, many excluded, 2/3 of SDCT not scanned, adjudication of primary endpoint, patient centered outcomes not the primary outcome
  • Key questions: When, Where, Type of CT and CCTA?

 

Bottom Line: 

  • CT head, gated CTA, venous abd/pelvis may improve early diagnosis; no difference in survival to discharge. 
  • CT can provide important information. Consider CT on the way up to the ICU once stabilized.

Share This:

Leave a Comment

Your email address will not be published. Required fields are marked *

emDOCs subscribes to the Free Open Access Meducation (FOAMed) initiative. Our goal is to inform the global EM community with timely and high-yield content about what providers like YOU are seeing and doing daily in your local ED.

WRITE FOR EMDOCS

We are actively recruiting both new topics and authors.
This project is rolling and you can submit an idea or write-up anytime!
Contact us at editors@emdocs.net

news, headlines, newsletter

Join our Newsletter

Keep up to date on all of the latest new articles, studies, and Podcasts.